Showing results (41-50 of 210) with videos related to
Sort By:
Pageof 21
The Tohoku Journal of Experimental Medicine|July 10, 2020
Clinical Features of Disaster-Associated Direct Deaths during Recent Inland Earthquakes in JapanHisaki Naito, Daisuke Sueta, Hideki Nakayama, et al.Journal of Diabetes Investigation|May 17, 2016
Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment periodEiichi Araki, Yukiko Onishi, Michiko Asano, et al.Current Diabetes Reviews|June 21, 2011
Heat shock response regulates insulin sensitivity and glucose homeostasis: pathophysiological impact and therapeutic potentialTatsuya Kondo, Saori Koga, Rina Matsuyama, et al.Antioxidants & Redox Signaling|August 8, 2020
Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic MiceAyaka Yoshinaga, Nobuhiro Kajihara, Daisuke Kukidome, et al.Diabetes & Metabolism Journal|May 23, 2014
The role of heat shock response in insulin resistance and diabetesTatsuya Kondo, Hiroyuki Motoshima, Motoyuki Igata, et al.Diabetes, Obesity & Metabolism|September 2, 2021
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trialsEiichi Araki, Yasuo Terauchi, Hirotaka Watada, et al.Diabetology International|January 4, 2019
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.Journal of Diabetes Investigation|December 10, 2016
New glycemic targets for patients with diabetes from the Japan Diabetes SocietyEiichi Araki, Masakazu Haneda, Masato Kasuga, et al.Diabetes, Obesity & Metabolism|August 14, 2019
Superior efficacy with a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin-naïve Japanese patients with type 2 diabetes in a phase 3, open-label, randomized trialKohei Kaku, Eiichi Araki, Yukio Tanizawa, et al.Acta Medica Okayama|August 25, 2018
Study Design of a Phase II Clinical Trial to Assess the Efficacy and Safety of Eperisone in Japanese Type 2 Diabetes Patients with Risk and Non-risk Alleles of CDKAL1Kourin Sakakida, Fan-Yan Wei, Takafumi Senokuchi, et al.Pageof 21